WAT · Earnings call · 2026Q2T · Full report

Competition and Market Share

WATERS CORP /DE/ · 2026-08-04 · Importance 60 · Surprise 74

Waters is pursuing share recapture in Flow Research, particularly in China, where improved export-license approval speed helped reduce the decline from 30% in the first quarter to a mid-single-digit decline in the second quarter. The FACSDiscover A7 is intended to close a portfolio gap and set a new benchmark in spectral flow cytometry through IVD-level standardization, reproducibility, automation and cell calibration. BACTEC FXI is positioned against competing blood-culture systems through faster detection, greater input capacity and productivity benefits. Waters also sees share recapture and replacement opportunities across its flow-cytometry installed base.